
Cary Ellen Wehner
Examiner (ID: 13799, Phone: (571)272-4715 , Office: P/3993 )
| Most Active Art Unit | 3303 |
| Art Unit(s) | 3616, 2876, 2303, 3303, 3732, 3993, 3736 |
| Total Applications | 2640 |
| Issued Applications | 2202 |
| Pending Applications | 182 |
| Abandoned Applications | 255 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20650461
[patent_doc_number] => 20260102472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-16
[patent_title] => SEMAGLUTIDE IN MEDICAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 19/422732
[patent_app_country] => US
[patent_app_date] => 2025-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19422732
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/422732 | SEMAGLUTIDE IN MEDICAL THERAPY | Dec 16, 2025 | Pending |
Array
(
[id] => 20541169
[patent_doc_number] => 20260048057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-19
[patent_title] => ANTI-ISCHEMIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 19/369023
[patent_app_country] => US
[patent_app_date] => 2025-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19369023
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/369023 | ANTI-ISCHEMIC COMPOSITIONS | Oct 23, 2025 | Pending |
Array
(
[id] => 20134951
[patent_doc_number] => 20250241995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-31
[patent_title] => METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES
[patent_app_type] => utility
[patent_app_number] => 19/098553
[patent_app_country] => US
[patent_app_date] => 2025-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19098553
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/098553 | Method of using a GIP/GLP1 co-agonist for diabetes | Apr 1, 2025 | Issued |
Array
(
[id] => 19930352
[patent_doc_number] => 12303545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Polypeptide with anti-
[patent_app_type] => utility
[patent_app_number] => 18/824970
[patent_app_country] => US
[patent_app_date] => 2024-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/824970 | Polypeptide with anti- | Sep 4, 2024 | Issued |
Array
(
[id] => 19601090
[patent_doc_number] => 20240391970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/670613
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670613 | COMPOSITIONS AND METHODS FOR TREATMENT OF FUNGAL INFECTIONS | May 20, 2024 | Pending |
Array
(
[id] => 19845285
[patent_doc_number] => 20250090636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => H3.3 CTL PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/667792
[patent_app_country] => US
[patent_app_date] => 2024-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667792
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/667792 | H3.3 CTL PEPTIDES AND USES THEREOF | May 16, 2024 | Pending |
Array
(
[id] => 19601073
[patent_doc_number] => 20240391953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/652429
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652429 | TUMOR ASSOCIATED MONOCYTE/MACROPHAGE BINDING PEPTIDE AND METHODS OF USE THEREOF | Apr 30, 2024 | Pending |
Array
(
[id] => 20757141
[patent_doc_number] => 12649900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Photostabilized compositions and a method for stabilizing photosensitive components
[patent_app_type] => utility
[patent_app_number] => 18/602421
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 716
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/602421 | Photostabilized compositions and a method for stabilizing photosensitive components | Mar 11, 2024 | Issued |
Array
(
[id] => 20413004
[patent_doc_number] => 12496266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Skin care product with protein matrix
[patent_app_type] => utility
[patent_app_number] => 18/594290
[patent_app_country] => US
[patent_app_date] => 2024-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 30
[patent_no_of_words] => 2353
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594290
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/594290 | Skin care product with protein matrix | Mar 3, 2024 | Issued |
Array
(
[id] => 19246835
[patent_doc_number] => 20240197819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => METHODS OF TREATING ALZHEIMERS DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/417206
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417206
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417206 | Methods of treating Alzheimers disease | Jan 18, 2024 | Issued |
Array
(
[id] => 19846742
[patent_doc_number] => 20250092093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => Androgen receptor protein degradation-inducing peptides for prostate cancer treatment
[patent_app_type] => utility
[patent_app_number] => 18/470073
[patent_app_country] => US
[patent_app_date] => 2023-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/470073 | Androgen receptor protein degradation-inducing peptides for prostate cancer treatment | Dec 30, 2023 | Pending |
Array
(
[id] => 19318306
[patent_doc_number] => 20240239848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => HOLOTHURIAN-DERIVED ACTIVE PEPTIDE WITH IMMUNE ACTIVITY, PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/396269
[patent_app_country] => US
[patent_app_date] => 2023-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18396269
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/396269 | HOLOTHURIAN-DERIVED ACTIVE PEPTIDE WITH IMMUNE ACTIVITY, PREPARATION METHOD AND APPLICATION THEREOF | Dec 25, 2023 | Pending |
Array
(
[id] => 19112776
[patent_doc_number] => 20240124526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS
[patent_app_type] => utility
[patent_app_number] => 18/394401
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394401 | Insulin like growth factor binding protein bioactive peptide fragments | Dec 21, 2023 | Issued |
Array
(
[id] => 19232202
[patent_doc_number] => 20240189393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
[patent_app_type] => utility
[patent_app_number] => 18/541847
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541847
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/541847 | COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY | Dec 14, 2023 | Pending |
Array
(
[id] => 20818513
[patent_doc_number] => 12673974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
[patent_app_type] => utility
[patent_app_number] => 18/527006
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 57728
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 358
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527006
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527006 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | Nov 30, 2023 | Issued |
Array
(
[id] => 19960369
[patent_doc_number] => 12329841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Odorant-binding protein compositions, methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/520428
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1811
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18520428
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/520428 | Odorant-binding protein compositions, methods and uses thereof | Nov 26, 2023 | Issued |
Array
(
[id] => 19049357
[patent_doc_number] => 20240091326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => Treatment of Glaucoma by Neuroprotection
[patent_app_type] => utility
[patent_app_number] => 18/518981
[patent_app_country] => US
[patent_app_date] => 2023-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518981
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/518981 | Treatment of Glaucoma by Neuroprotection | Nov 24, 2023 | Pending |
Array
(
[id] => 19032547
[patent_doc_number] => 20240082362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/510327
[patent_app_country] => US
[patent_app_date] => 2023-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18510327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/510327 | GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY | Nov 14, 2023 | Abandoned |
Array
(
[id] => 19001951
[patent_doc_number] => 20240066022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
[patent_app_type] => utility
[patent_app_number] => 18/387450
[patent_app_country] => US
[patent_app_date] => 2023-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18387450
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/387450 | DIIODOHYDROXYQUINOLINE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION | Nov 5, 2023 | Abandoned |
Array
(
[id] => 19112804
[patent_doc_number] => 20240124554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS AND CANCER
[patent_app_type] => utility
[patent_app_number] => 18/482589
[patent_app_country] => US
[patent_app_date] => 2023-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18482589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/482589 | VEGF TRAPS AND MINI-TRAPS AND METHODS FOR TREATING OCULAR DISORDERS AND CANCER | Oct 5, 2023 | Pending |